GB0714556D0 - Overcoming anticancer drug resistance - Google Patents
Overcoming anticancer drug resistanceInfo
- Publication number
- GB0714556D0 GB0714556D0 GB0714556A GB0714556A GB0714556D0 GB 0714556 D0 GB0714556 D0 GB 0714556D0 GB 0714556 A GB0714556 A GB 0714556A GB 0714556 A GB0714556 A GB 0714556A GB 0714556 D0 GB0714556 D0 GB 0714556D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- drug resistance
- anticancer drug
- overcoming anticancer
- overcoming
- resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0714556A GB0714556D0 (en) | 2007-07-26 | 2007-07-26 | Overcoming anticancer drug resistance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0714556A GB0714556D0 (en) | 2007-07-26 | 2007-07-26 | Overcoming anticancer drug resistance |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0714556D0 true GB0714556D0 (en) | 2007-09-05 |
Family
ID=38512892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0714556A Ceased GB0714556D0 (en) | 2007-07-26 | 2007-07-26 | Overcoming anticancer drug resistance |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0714556D0 (en) |
-
2007
- 2007-07-26 GB GB0714556A patent/GB0714556D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237391A0 (en) | Pharmaceutical combination | |
PL2200593T3 (en) | Abuse resistant drug formulation | |
IL219001A0 (en) | Drug delivery device | |
EP2242514A4 (en) | Intralymphatic chemotherapy drug carriers | |
HK1141462A1 (en) | Polymers conjugated with platinum drugs | |
ZA200806318B (en) | Drug combinations | |
GB0721332D0 (en) | Medicaments | |
HK1152640A1 (en) | Pharmaceutical combination | |
IL207538A0 (en) | Genetic variations associated with drug resistance | |
IL197883A0 (en) | Combination drug | |
IL212603A0 (en) | Combined drug administration | |
EP2105140A4 (en) | Anticancer agent | |
GB0721333D0 (en) | Medicaments | |
GB0717450D0 (en) | Medicament | |
GB0714556D0 (en) | Overcoming anticancer drug resistance | |
GB0809843D0 (en) | Overcoming anticancer drug resistance | |
GB0710771D0 (en) | Overcoming drug resistance | |
HUP0800414A2 (en) | Pharmaceutical combination | |
GB0713426D0 (en) | Improvements in anticancer drugs | |
GB0811599D0 (en) | Improvements in anticancer drugs | |
GB0712568D0 (en) | Overcoming between beta-lactam drug resistance | |
ZA200710986B (en) | Anti-AIDS drug | |
GB201002189D0 (en) | Overcoming drug resistance | |
ZA200902756B (en) | Combination drug | |
GB0812944D0 (en) | Improvements in antimicrobial drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |